title: Pregnancy after chemotherapy for gestational trophoblastic disease.
abstract: Forty-nine women who had received chemotherapy for gestational trophoblastic disease subsequently became pregnant a total of 65 times. Of these 65 pregnancies, 42 (64.7%) terminated in term births, 4 (6.1%) in premature births, 1 (1.5%) in stillbirth, 8 (2.3%) in spontaneous abortion and 7 (10.8%) in elective abortion, while 3 patients (4.6%) had repeat molar pregnancies. No congenital malformations or obstetric complications were observed. Treatment of gestational trophoblastic disease with chemotherapy is compatible with the preservation of fertility and is not associated with any increase in congenital fetal malformations.
authors.affiliation: Department of Obstetrics and Gynecology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
authors.forename: A
authors.initials: A
authors.lastname: Ayhan
authors.forename: M H
authors.initials: MH
authors.lastname: Ergeneli
authors.forename: K
authors.initials: K
authors.lastname: Yüce
authors.forename: E G
authors.initials: EG
authors.lastname: Yapar
authors.forename: A H
authors.initials: AH
authors.lastname: Kişnişçi
mesh_terms: D000293:Adolescent; D000328:Adult; D002822:Choriocarcinoma / Q000188:drug therapy; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D003609:Dactinomycin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy; D011256:Pregnancy Outcome; D014328:Trophoblastic Neoplasms / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000188:drug therapy*
chemical_list: D003609:Dactinomycin; D003520:Cyclophosphamide; D008727:Methotrexate